- Home
- LI vs RVMD Comparison
LI vs RVMD Comparison
Compare LI & RVMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LI | RVMD |
|---|---|---|
| Founded | 2015 | 2014 |
| Country | China | United States |
| Employees | N/A | 883 |
| Industry | Auto Manufacturing | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 16.8B | 19.1B |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LI | RVMD |
|---|---|---|
| Price | $18.43 | $98.34 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 10 | 17 |
| Target Price | $19.66 | ★ $120.47 |
| AVG Volume (30 Days) | ★ 3.3M | 1.6M |
| Earning Date | 03-12-2026 | 05-06-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $24.20 | N/A |
| Revenue Next Year | $22.91 | $408.69 |
| P/E Ratio | $29.50 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $15.71 | $29.17 |
| 52 Week High | $32.03 | $124.49 |
Technical Indicators
Market Signals| Indicator | LI | RVMD |
|---|---|---|
| Relative Strength Index (RSI) | 57.53 | 52.84 |
| Support Level | $16.30 | $93.86 |
| Resistance Level | $18.92 | $107.45 |
| Average True Range (ATR) | 0.45 | 3.13 |
| MACD | 0.07 | 0.06 |
| Stochastic Oscillator | 74.20 | 76.31 |
Price Performance
Historical ComparisonAbout LI Li Auto Inc.
Li Auto is a leading Chinese NEV manufacturer that designs, develops, manufactures, and sells premium smart NEVs. The company started volume production of its first model Li One in November 2019. The model is a six-seater, large, premium plug-in electric SUV equipped with a range extension system and advanced smart vehicle solutions. It sold over 500,000 NEVs in 2024, accounting for about 4% of China's passenger new energy vehicle market. Beyond Li One, the company expands its product line, including both BEVs and PHEVs, to target a broader consumer base.
About RVMD Revolution Medicines Inc.
Revolution Medicines Inc is a clinical-stage precision oncology company developing novel targeted therapies for RAS-addicted cancers. The Company possesses structure-based drug discovery capabilities built upon chemical biology and cancer pharmacology know-how and proprietary technologies that enable the creation of small molecules tailored to unconventional binding sites. Its research and development pipeline comprises inhibitors that bind directly to RAS variants (RAS(ON) Inhibitors), designed to be used as monotherapy, in combination with other RAS(ON) Inhibitors and/or other therapeutic agents.